IMG 2519

Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China

Croma announced today that in June the first patient will be enrolled in the clinical trial1 for the approval of its hyaluronic acid dermal filler Princess® Volume Plus Lidocaine2 in China.


If you are a healthcare professional (HCP), please log in to see specific information about our products.



* fields are required